Increased Protein Kinase C Activity and Expression of Ca <sup>2+</sup> -Sensitive Isoforms in the Failing Human Heart
Nancy Bowling(Joslin Diabetes Center), Chris J. Vlahos(Eli Lilly (United States)), Michael R. Bristow(University of Colorado Health), Gianni Gromo(Roche (Switzerland)), George E. Sandusky(Indiana University – Purdue University Indianapolis), Todd Pickard(Joslin Diabetes Center), Jacques Mizrahi, Hani N. Sabbah(Henry Ford Hospital), Thomas Estridge(Joslin Diabetes Center), Guojie Song(Joslin Diabetes Center), Robert L. Roden(Joslin Diabetes Center), Richard A. Walsh(University College Dublin), George L. King(Joslin Diabetes Center), Rebecca L. Fouts(Joslin Diabetes Center), Karen Mintze(Joslin Diabetes Center)
Cited by 457
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies
|Circulation|1996|3.5k
A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).
|Journal of Biological Chemistry|1994|3.3k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k